AXL and melanoma: Feedback reactivation of RTKs induced by treatment can also occur through post-translational mechanisms, as it has been shown in melanoma and breast cancer cells, where MAPK inhibition can reduce the proteolytic shedding of AXL, MET and HER4, thus increasing the levels of these receptors at the cell surface [21].